Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation

Molecular Systems Biology

Volumn 7, Issue 1, 2011, Pages

  Kratochvill, Franz ^a   Machacek, Christian ^a   Vogl, Claus ^b   Ebner, Florian ^a   Sedlyarov, Vitaly ^a   Gruber, Andreas R ^c   Hartweger, Harald ^a   Vielnascher, Raimund ^b   Karaghiosoff, Marina ^b   Rülicke, Thomas ^b   Müller, Mathias ^b   Hofacker, Ivo ^c   Lang, Roland ^d   Kovarik, Pavels ^a  

^a MAX F PERUTZ LABORATORIES   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

immune homeostasis; inflammation; mRNA stability; p38 MAPK; tristetraprolin

Indexed keywords

MUS;

CYTOKINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTOME; TRISTETRAPROLIN;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMISTRY; FEMALE; GENETICS; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; MALE; METABOLISM; MOUSE; MOUSE MUTANT; RNA STABILITY;

ANIMALS; CYTOKINES; FEMALE; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RNA STABILITY; RNA, MESSENGER; TRANSCRIPTOME; TRISTETRAPROLIN;

EID: 84865179916     PISSN: None     EISSN: 17444292     Source Type: Journal    
DOI: 10.1038/msb.2011.93     Document Type: Article

References (54)

1. Abdelmohsen K, Lal A, Kim HH, Gorospe M, (2007) Posttranscriptional orchestration of an anti-apoptotic program by HuR. Cell Cycle 6: 1288-1292
2. Anderson P, (2010) Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat Rev 10: 24-35
3. Barreau C, Paillard L, Osborne HB, (2005) AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 33: 7138-7150
4. Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, Grunig G, Rennick D, (1995) Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96: 2339-2347
5. Blackshear PJ, (2002) Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem Soc Trans 30 (Part 6): 945-952
6. Blackshear PJ, Lai WS, Kennington EA, Brewer G, Wilson GM, Guan X, Zhou P, (2003) Characteristics of the interaction of a synthetic human tristetraprolin tandem zinc finger peptide with AU-rich element-containing RNA substrates. J Biol Chem 278: 19947-19955
7. Cairrao F, Halees AS, Khabar KS, Morello D, Vanzo N, (2009) AU-rich elements regulate Drosophila gene expression. Mol Cell Biol 29: 2636-2643
8. Carballo E, Lai WS, Blackshear PJ, (1998) Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281: 1001-1005
9. Carballo E, Lai WS, Blackshear PJ, (2000) Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95: 1891-1899
10. Cheadle C, Fan J, Cho-Chung YS, Werner T, Ray J, Do L, Gorospe M, Becker KG, (2005) Stability regulation of mRNA and the control of gene expression. Ann NY Acad Sci 1058: 196-204
11. Chekulaeva M, Filipowicz W, (2009) Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 21: 452-460
12. Chen YL, Huang YL, Lin NY, Chen HC, Chiu WC, Chang CJ, (2006) Differential regulation of ARE-mediated TNFalpha and IL-1beta mRNA stability by lipopolysaccharide in RAW264.7 cells. Biochem Biophys Res Commun 346: 160-168
13. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I, (1999) Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8: 265-277
14. Dahan O, Gingold H, Pilpel Y, (2011) Regulatory mechanisms and networks couple the different phases of gene expression. Trends Genet 27: 316-322
15. Datta S, Biswas R, Novotny M, Pavicic Jr PG., Herjan T, Mandal P, Hamilton TA, (2008) Tristetraprolin regulates CXCL1 (KC) mRNA stability. J Immunol 180: 2545-2552
16. Emmons J, Townley-Tilson WH, Deleault KM, Skinner SJ, Gross RH, Whitfield ML, Brooks SA, (2008) Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation. RNA 14: 888-902
17. Frasca D, Landin AM, Alvarez JP, Blackshear PJ, Riley RL, Blomberg BB, (2007) Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA. J Immunol 179: 918-927
18. Gama-Carvalho M, Barbosa-Morais NL, Brodsky AS, Silver PA, Carmo-Fonseca M, (2006) Genome-wide identification of functionally distinct subsets of cellular mRNAs associated with two nucleocytoplasmic-shuttling mammalian splicing factors. Genome Biol 7: R113
19. Ghosh M, Aguila HL, Michaud J, Ai Y, Wu MT, Hemmes A, Ristimaki A, Guo C, Furneaux H, Hla T, (2009) Essential role of the RNA-binding protein HuR in progenitor cell survival in mice. J Clin Invest 119: 3530-3543
20. Grivennikov SI, Tumanov AV, Liepinsh DJ, Kruglov AA, Marakusha BI, Shakhov AN, Murakami T, Drutskaya LN, Forster I, Clausen BE, Tessarollo L, Ryffel B, Kuprash DV, Nedospasov SA, (2005) Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. Immunity 22: 93-104
21. Gruber AR, Fallmann J, Kratochvill F, Kovarik P, Hofacker IL, (2011) AREsite: a database for the comprehensive investigation of AU-rich elements. Nucleic Acids Res 39 (Database issue): D66-D69
22. Hammer M, Mages J, Dietrich H, Schmitz F, Striebel F, Murray PJ, Wagner H, Lang R, (2005) Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10. Eur J Immunol 35: 2991-3001
23. Hammer M, Mages J, Dietrich H, Servatius A, Howells N, Cato AC, Lang R, (2006) Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med 203: 15-20
24. Hao S, Baltimore D, (2009) The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol 10: 281-288
25. Hodson DJ, Janas ML, Galloway A, Bell SE, Andrews S, Li CM, Pannell R, Siebel CW, MacDonald HR, De Keersmaecker K, Ferrando AA, Grutz G, Turner M, (2010) Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia. Nat Immunol 11: 717-724
26. Horner TJ, Lai WS, Stumpo DJ, Blackshear PJ, (2009) Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin. Mol Cell Biol 29: 1999-2010
27. Hume DA, Wells CA, Ravasi T, (2007) Transcriptional regulatory networks in macrophages. Novartis Found Symp 281: 2-18; discussion 18-24, 50-13, 208-209
28. Jalonen U, Nieminen R, Vuolteenaho K, Kankaanranta H, Moilanen E, (2006) Down-regulation of tristetraprolin expression results in enhanced IL-12 and MIP-2 production and reduced MIP-3alpha synthesis in activated macrophages. Mediators Inflamm 2006: 40691
29. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G, (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10: 387-398
30. Lai WS, Carballo E, Thorn JM, Kennington EA, Blackshear PJ, (2000) Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA. J Biol Chem 275: 17827-17837
31. Lai WS, Parker JS, Grissom SF, Stumpo DJ, Blackshear PJ, (2006) Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol Cell Biol 26: 9196-9208
32. Litvak V, Ramsey SA, Rust AG, Zak DE, Kennedy KA, Lampano AE, Nykter M, Shmulevich I, Aderem A, (2009) Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat Immunol 10: 437-443
33. Mages J, Dietrich H, Lang R, (2007) A genome-wide analysis of LPS tolerance in macrophages. Immunobiology 212: 723-737
34. Morrison TB, Weis JJ, Wittwer CT, (1998) Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 24: 954-958, 960, 962
35. Mukherjee N, Lager PJ, Friedersdorf MB, Thompson MA, Keene JD, (2009) Coordinated posttranscriptional mRNA population dynamics during T-cell activation. Mol Syst Biol 5: 288
36. Murray PJ, (2005) The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc Natl Acad Sci USA 102: 8686-8691
37. Ogilvie RL, Abelson M, Hau HH, Vlasova I, Blackshear PJ, Bohjanen PR, (2005) Tristetraprolin down-regulates IL-2 gene expression through AU-Rich element-mediated mRNA decay. J Immunol 174: 953-961
38. Ogilvie RL, Sternjohn JR, Rattenbacher B, Vlasova IA, Williams DA, Hau HH, Blackshear PJ, Bohjanen PR, (2009) Tristetraprolin mediates interferon-gamma mRNA decay. J Biol Chem 284: 11216-11223
39. Puig S, Askeland E, Thiele DJ, (2005) Coordinated remodeling of cellular metabolism during iron deficiency through targeted mRNA degradation. Cell 120: 99-110
40. Raghavan A, Bohjanen PR, (2004) Microarray-based analyses of mRNA decay in the regulation of mammalian gene expression. Brief Funct Genomic Proteomic 3: 112-124
41. Sandler H, Stoecklin G, (2008) Control of mRNA decay by phosphorylation of tristetraprolin. Biochem Soc Trans 36 (Part 3): 491-496
42. Schaljo B, Kratochvill F, Gratz N, Sadzak I, Sauer I, Hammer M, Vogl C, Strobl B, Muller M, Blackshear PJ, Poli V, Lang R, Murray PJ, Kovarik P, (2009) Tristetraprolin is required for full anti-inflammatory response of murine macrophages to IL-10. J Immunol 183: 1197-1206
43. Smyth GK, (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3
44. Stoecklin G, Anderson P, (2007) In a tight spot: ARE-mRNAs at processing bodies. Genes Dev 21: 627-631
45. Stoecklin G, Gross B, Ming XF, Moroni C, (2003) A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA. Oncogene 22: 3554-3561
46. Stoecklin G, Stoeckle P, Lu M, Muehlemann O, Moroni C, (2001) Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements. RNA 7: 1578-1588
47. Stoecklin G, Tenenbaum SA, Mayo T, Chittur SV, George AD, Baroni TE, Blackshear PJ, Anderson P, (2008) Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem 283: 11689-11699
48. Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, Schenkman DI, Gilkeson GS, Broxmeyer HE, Haynes BF, Blackshear PJ, (1996) A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4: 445-454
49. Tchen CR, Brook M, Saklatvala J, Clark AR, (2004) The stability of tristetraprolin mRNA is regulated by mitogen activated protein kinase p38 and by tristetraprolin itself. J Biol Chem 279: 32393-32400
50. Tudor C, Marchese FP, Hitti E, Aubareda A, Rawlinson L, Gaestel M, Blackshear PJ, Clark AR, Saklatvala J, Dean JL, (2009) The p38 MAPK pathway inhibits tristetraprolin-directed decay of interleukin-10 and pro-inflammatory mediator mRNAs in murine macrophages. FEBS Lett 583: 1933-1938
51. von Roretz C, Gallouzi IE, (2008) Decoding ARE-mediated decay: is microRNA part of the equation? J Cell Biol 181: 189-194
52. Wakeland E, Morel L, Achey K, Yui M, Longmate J, (1997) Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol Today 18: 472-477
53. Worthington MT, Pelo JW, Sachedina MA, Applegate JL, Arseneau KO, Pizarro TT, (2002) RNA binding properties of the AU-rich element-binding recombinant Nup475/TIS11/tristetraprolin protein. J Biol Chem 277: 48558-48564
54. Zhao W, Liu M, D'Silva NJ, Kirkwood KL, (2011) Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3′ untranslated region. J Interferon Cytokine Res 31: 629-637